SS Innovations International (NASDAQ: SSII) has appointed Sarah M. Romano as chief financial officer, effective August 3, 2026, as the surgical robotics developer accelerates its global commercialization and regulatory initiatives. Romano, a veteran medtech finance executive with over two decades of experience in public-company finance, capital markets, and medical technology, has raised more than $100 million during her career. She previously served as CFO at Vicarious Surgical, another developer of robotic surgical technologies, where she led financial and operational strategies to reduce cash burn and strengthen the balance sheet.
The appointment comes at a pivotal time for SS Innovations as it continues pursuing U.S. Food and Drug Administration clearance for its SSi Mantra surgical robotic system while expanding internationally. The company recently graduated the inaugural class of its SS International Centre for Robotics Surgery (SSICRS) cardiac robotic surgery training program, which welcomed 33 healthcare professionals from seven countries. This underscores SS Innovations' emphasis on surgeon education alongside technology deployment, a key factor in the adoption of robotic surgery platforms.
Romano's expertise in capital markets and financial management is expected to support SS Innovations' growth trajectory as it navigates the regulatory pathway and expands its presence in global markets. The company's SSi Mantra platform aims to provide a versatile robotic surgery solution, and the expansion of training programs like SSICRS is critical to ensuring successful integration into healthcare systems.
For more information, see the full press release on the InvestorBrandNetwork website: https://nnw.fm/yY4UM. Forward-looking statements in this article are subject to risks and uncertainties, as detailed in the company's SEC filings. For updates on SS Innovations, visit the company's newsroom: https://ibn.fm/SSII.
